Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Queensland, Australia, April 22, 2021 (GLOBE NEWSWIRE) — Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international healthcare company specializing in the manufacturing of alternative medicine products and services across the entire value chain, today announces the appointment of Mrs. Leilani Latimer as Non-Executive Director of Rayont Inc.
“We are pleased with the appointment of Mrs. Latimer. As the new board director, she brings long experience in growing and scaling businesses in Silicon Valley and globally. Her skills and experience will help the business expansion of Rayont to become a world-class healthcare company.” said Mr. Reyad Fezzani, Chairman of the Board of Directors of Rayont Inc.
Leilani Latimer – Non-Executive Director
Leilani Latimer is a go-to-market executive and board director with a track record of growing B2B, SaaS, enterprise software companies – public, pre-IPO and start-ups. Ms. Latimer is currently an Independent Director at Black Diamond Group (TSE: BDI) and a Growth Advisor at WellKom International. Her board experience includes participation on Executive, Nominating and Governance committees, and she has held numerous Board Advisory roles with Silicon Valley-based and global start-ups, as well as the Chairmanship of a national non-profit organization.
Mrs. Latimer is the Chief…
